{"symbol": "LLY", "publishedDate": "2024-04-16 10:00:00", "publisher": "PRNewsWire", "title": "Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement", "image": "https://images.financialmodelingprep.com/news/lilly-confirms-date-and-conference-call-for-firstquarter-2024-20240416.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , April 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2024 financial results on April 30, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.", "url": "https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-first-quarter-2024-financial-results-announcement-302117160.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-16T10:00:00-04:00", "date_et": "2024-04-16"}
{"symbol": "LLY", "publishedDate": "2024-04-16 18:51:22", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-stock-dips-while-market-gains-key-20240416.jpg", "site": "zacks.com", "text": "In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.", "url": "https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2256381", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-16T18:51:22-04:00", "date_et": "2024-04-16"}
{"symbol": "LLY", "publishedDate": "2024-04-16 19:09:00", "publisher": "Market Watch", "title": "Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.", "image": "https://images.financialmodelingprep.com/news/big-pharma-is-looking-to-fatten-profits-with-buyouts-20240416.jpg", "site": "marketwatch.com", "text": "A couple of big-picture trends in biotech could add up to a nice investment opportunity. First, corporate buyouts are back in style.", "url": "https://www.marketwatch.com/story/big-pharma-is-looking-to-fatten-profits-with-buyouts-of-weight-loss-drug-companies-here-are-4-candidates-6ffe2550", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-16T19:09:00-04:00", "date_et": "2024-04-16"}
{"symbol": "LLY", "publishedDate": "2024-04-17 09:38:58", "publisher": "Reuters", "title": "Most doses of Lilly's Mounjaro and Zepbound in limited availability, US FDA says", "image": "https://images.financialmodelingprep.com/news/most-doses-of-lillys-mounjaro-and-zepbound-in-limited-20240417.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be available in limited amounts through the second quarter of this year due to increased demand.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/most-doses-lillys-mounjaro-zepbound-limited-availability-us-fda-says-2024-04-17/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-17T09:38:58-04:00", "date_et": "2024-04-17"}
{"symbol": "LLY", "publishedDate": "2024-04-17 11:23:17", "publisher": "CNBC", "title": "Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says", "image": "https://images.financialmodelingprep.com/news/most-doses-of-eli-lillys-zepbound-mounjaro-in-short-20240417.jpeg", "site": "cnbc.com", "text": "The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.", "url": "https://www.cnbc.com/2024/04/17/eli-lillys-zepbound-mounjaro-in-short-supply-through-june-fda-says-.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-17T11:23:17-04:00", "date_et": "2024-04-17"}
{"symbol": "LLY", "publishedDate": "2024-04-17 18:51:53", "publisher": "The Motley Fool", "title": "Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank", "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-stock-beat-the-market-today-while-20240417.jpg", "site": "fool.com", "text": "One of the pharmaceutical giant's hotter medications tested well for a new indication. It has already attracted much attention for the molecule being studied, as it's used in two FDA-approved treatments already.", "url": "https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-17T18:51:53-04:00", "date_et": "2024-04-17"}
{"symbol": "LLY", "publishedDate": "2024-04-18 05:10:00", "publisher": "The Motley Fool", "title": "2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years", "image": "https://images.financialmodelingprep.com/news/2-growth-stocks-that-turned-10000-into-more-than-20240418.jpg", "site": "fool.com", "text": "Tesla's transformation over the past 10 years has made it one of the most valuable stocks on Wall Street. The excitement around a highly promising weight-loss drug has made Eli Lilly a hot buy in recent years.", "url": "https://www.fool.com/investing/2024/04/18/growth-stocks-turn-10k-into-more-than-100k/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-18T05:10:00-04:00", "date_et": "2024-04-18"}
{"symbol": "LLY", "publishedDate": "2024-04-18 11:35:05", "publisher": "Proactive Investors", "title": "Big pharma: cautious optimism ahead of earnings season - analysts", "image": "https://images.financialmodelingprep.com/news/big-pharma-cautious-optimism-ahead-of-earnings-season-analysts-20240418.jpg", "site": "proactiveinvestors.com", "text": "Looking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at several major names. Notably, Eli Lilly and Co (NYSE:LLY), with a 'buy' rating and a price target of $910, is expected to see mixed performance due to shortages of its weightloss drig Mounjaro and Zepbound, though early stocking could partially offset declines in Trulicity sales.", "url": "https://www.proactiveinvestors.com/companies/news/1045643?SNAPI", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-18T11:35:05-04:00", "date_et": "2024-04-18"}
{"symbol": "LLY", "publishedDate": "2024-04-18 11:35:05", "publisher": "Proactive Investors", "title": "Big pharma: cautious optimism ahead of earnings season - analysts", "image": "https://images.financialmodelingprep.com/news/big-pharma-cautious-optimism-ahead-of-earnings-season-analysts-20240418.jpg", "site": "proactiveinvestors.com", "text": "Looking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at several major names. Notably, Eli Lilly and Co (NYSE:LLY), with a 'buy' rating and a price target of $910, is expected to see mixed performance due to shortages of its weightloss drig Mounjaro and Zepbound, though early stocking could partially offset declines in Trulicity sales.", "url": "https://www.proactiveinvestors.com/companies/news/1045643", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-18T11:35:05-04:00", "date_et": "2024-04-18"}
{"symbol": "LLY", "publishedDate": "2024-04-19 07:30:00", "publisher": "InvestorPlace", "title": "Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now", "image": "https://images.financialmodelingprep.com/news/strong-buy-alert-7-nobrainer-stocks-to-scoop-up-20240419.jpg", "site": "investorplace.com", "text": "When Wall Street tags a stock as a strong buy, it is probably right. Generally speaking, such shares tend to be among the best positioned investments in the market.", "url": "https://investorplace.com/2024/04/strong-buy-alert-7-no-brainer-stocks-to-scoop-up-now/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-19T07:30:00-04:00", "date_et": "2024-04-19"}
{"symbol": "LLY", "publishedDate": "2024-04-20 06:48:00", "publisher": "The Motley Fool", "title": "3 Relatively Safe Growth Stocks You Can Buy and Hold", "image": "https://images.financialmodelingprep.com/news/3-relatively-safe-growth-stocks-you-can-buy-and-20240420.jpg", "site": "fool.com", "text": "Eli Lilly has crushed the S&P 500 over the last 12 months and could continue delivering outsized returns. Novo Nordisk's strong fundamentals and solid growth opportunities make it a no-brainer buy.", "url": "https://www.fool.com/investing/2024/04/20/relatively-safe-growth-stocks-you-can-buy-and-hold/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-20T06:48:00-04:00", "date_et": "2024-04-20"}
{"symbol": "LLY", "publishedDate": "2024-04-22 11:54:19", "publisher": "Reuters", "title": "Eli Lilly to acquire manufacturing facility from Nexus Pharma", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-acquire-manufacturing-facility-from-nexus-pharma-20240422.jpg", "site": "reuters.com", "text": "Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-22T11:54:19-04:00", "date_et": "2024-04-22"}
{"symbol": "LLY", "publishedDate": "2024-04-22 13:43:04", "publisher": "InvestorPlace", "title": "7 High-Flying Stocks That Are Majorly Overdue for a Pullback", "image": "https://images.financialmodelingprep.com/news/7-highflying-stocks-that-are-majorly-overdue-for-a-20240422.jpg", "site": "investorplace.com", "text": "There's plenty out there that could potentially drive a broad market pullback, but there are also plenty of individual stocks due for a pullback. Irrespective how the market performs from here, these types of stocks may be in for considerable declines in price.", "url": "https://investorplace.com/2024/04/7-high-flying-stocks-that-are-majorly-overdue-for-a-pullback/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-22T13:43:04-04:00", "date_et": "2024-04-22"}
{"symbol": "LLY", "publishedDate": "2024-04-22 18:51:17", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Advances But Underperforms Market: Key Facts", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-advances-but-underperforms-market-key-facts-20240422.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.", "url": "https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2259608", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-22T18:51:17-04:00", "date_et": "2024-04-22"}
{"symbol": "LLY", "publishedDate": "2024-04-23 05:00:00", "publisher": "Business Wire", "title": "Hagens Berman Signals Major Turning Point in Insulin Fair Pricing Class-Action Lawsuit", "image": "https://images.financialmodelingprep.com/news/hagens-berman-signals-major-turning-point-in-insulin-fair-20240423.jpg", "site": "businesswire.com", "text": "NEWARK, N.J.--(BUSINESS WIRE)---- $LLY #T1D--A historic fair drug-pricing lawsuit has reached a milestone moment, according to attorneys at Hagens Berman and Carella Byrne Cecchi Olstein Brody & Agnello who represent a class of those living with diabetes fighting the rising price of insulin. The law firms first began the crusade against insulin-maker Eli Lilly in 2017 and have been leading the charge to make a difference for the millions of people who rely on insulin on a daily basis, and recent activity.", "url": "https://www.businesswire.com/news/home/20240423221662/en/Hagens-Berman-Signals-Major-Turning-Point-in-Insulin-Fair-Pricing-Class-Action-Lawsuit/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-23T05:00:00-04:00", "date_et": "2024-04-23"}
{"symbol": "LLY", "publishedDate": "2024-04-23 11:07:29", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-reports-next-week-wall-street-expects-20240423.jpg", "site": "zacks.com", "text": "Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/2260247/eli-lilly-lly-reports-next-week-wall-street-expects-earnings-growth?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2260247", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-23T11:07:29-04:00", "date_et": "2024-04-23"}
{"symbol": "LLY", "publishedDate": "2024-04-24 06:40:00", "publisher": "The Motley Fool", "title": "Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market", "image": "https://images.financialmodelingprep.com/news/meet-eli-lillys-secret-weapon-in-the-billiondollar-weightloss-20240424.jpg", "site": "fool.com", "text": "Demand is high for Eli Lilly's Zepbound, and the weight-loss drug market could reach $100 billion by the end of the decade. But one thing is getting in between some potential patients and this promising drug.", "url": "https://www.fool.com/investing/2024/04/24/meet-lilly-secret-weapon-in-weight-loss-market/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T06:40:00-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-24 10:06:24", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-eli-lilly-and-company-lly-here-is-20240424.jpg", "site": "zacks.com", "text": "Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "url": "https://www.zacks.com/stock/news/2260940/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2260940", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T10:06:24-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-24 10:26:07", "publisher": "Zacks Investment Research", "title": "Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?", "image": "https://images.financialmodelingprep.com/news/should-eli-lilly-lly-be-in-your-portfolio-ahead-20240424.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.", "url": "https://www.zacks.com/stock/news/2261017/should-eli-lilly-lly-be-in-your-portfolio-ahead-of-q1-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2261017", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T10:26:07-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-24 11:11:06", "publisher": "Zacks Investment Research", "title": "4 Large Drug Stocks to Hold on to Amid Industry Challenges", "image": "https://images.financialmodelingprep.com/news/4-large-drug-stocks-to-hold-on-to-amid-industry-20240424.jpg", "site": "zacks.com", "text": "Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.", "url": "https://www.zacks.com/commentary/2260758/4-large-drug-stocks-to-hold-on-to-amid-industry-challenges?cid=CS-STOCKNEWSAPI-FT-industry_outlook-2260758", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T11:11:06-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-24 13:06:03", "publisher": "Zacks Investment Research", "title": "Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?", "image": "https://images.financialmodelingprep.com/news/will-healthcare-etfs-lose-momentum-as-q1-earnings-unfold-20240424.jpg", "site": "zacks.com", "text": "While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.", "url": "https://www.zacks.com/stock/news/2261491/will-healthcare-etfs-lose-momentum-as-q1-earnings-unfold?cid=CS-STOCKNEWSAPI-FT-etf_news_and_commentary-2261491", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T13:06:03-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-24 14:51:49", "publisher": "InvestorPlace", "title": "Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses", "image": "https://images.financialmodelingprep.com/news/which-companies-will-join-the-trilliondollar-team-in-2024-20240424.png", "site": "investorplace.com", "text": "The majority of leading global indices reached new highs in 2024, fueled by loose financial conditions and burgeoning enthusiasm for artificial intelligence (AI). In the U.S., this rally pushed the S&P 500 to fresh highs.", "url": "https://investorplace.com/2024/04/which-companies-will-join-the-trillion-dollar-team-in-2024-our-3-best-guesses/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-24T14:51:49-04:00", "date_et": "2024-04-24"}
{"symbol": "LLY", "publishedDate": "2024-04-25 06:04:00", "publisher": "InvestorPlace", "title": "Don't Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List", "image": "https://images.financialmodelingprep.com/news/dont-miss-out-3-toptier-bluechip-growth-stocks-for-20240425.jpg", "site": "investorplace.com", "text": "Blue-chip growth stocks are all around us. Yet, finding the right fit for your particular portfolio is easier said than done.", "url": "https://investorplace.com/2024/04/dont-miss-out-3-top-tier-blue-chip-growth-stocks-for-your-must-buy-list/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-25T06:04:00-04:00", "date_et": "2024-04-25"}
{"symbol": "LLY", "publishedDate": "2024-04-25 10:20:22", "publisher": "Zacks Investment Research", "title": "Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics", "image": "https://images.financialmodelingprep.com/news/gear-up-for-lilly-lly-q1-earnings-wall-street-20240425.jpg", "site": "zacks.com", "text": "Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.", "url": "https://www.zacks.com/stock/news/2262065/gear-up-for-lilly-lly-q1-earnings-wall-street-estimates-for-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2262065", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-25T10:20:22-04:00", "date_et": "2024-04-25"}
{"symbol": "LLY", "publishedDate": "2024-04-26 09:00:42", "publisher": "Forbes", "title": "A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1", "image": "https://images.financialmodelingprep.com/news/a-3x-expected-rise-in-mounjaro-sales-is-likely-20240426.jpg", "site": "forbes.com", "text": "Eli Lilly stock (NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical giant is expected to garner $8.9 billion in sales and $2.46 in adjusted earnings per share, per the consensus estimates.", "url": "https://www.forbes.com/sites/greatspeculations/2024/04/26/a-3x-expected-rise-in-mounjaro-sales-is-likely-to-drive-eli-lillys-q1/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-26T09:00:42-04:00", "date_et": "2024-04-26"}
{"symbol": "LLY", "publishedDate": "2024-04-26 17:05:40", "publisher": "Investopedia", "title": "What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday", "image": "https://images.financialmodelingprep.com/news/what-you-need-to-know-ahead-of-eli-lillys-20240426.jpg", "site": "investopedia.com", "text": "Eli Lilly (LLY) reports earnings before the bell Tuesday, with investors and analysts watching to see how much weight-loss drugs are continuing to drive the company's growth.", "url": "https://www.investopedia.com/eli-lilly-q1-fy-2024-earnings-preview-8639462", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-26T17:05:40-04:00", "date_et": "2024-04-26"}
{"symbol": "LLY", "publishedDate": "2024-04-26 18:28:14", "publisher": "CNBC", "title": "Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly", "image": "https://images.financialmodelingprep.com/news/cramers-week-ahead-fed-meeting-and-earnings-from-apple-20240426.jpg", "site": "cnbc.com", "text": "CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.", "url": "https://www.cnbc.com/2024/04/26/cramers-week-ahead-fed-meeting-and-apple-amazon-eli-lilly-report.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-26T18:28:14-04:00", "date_et": "2024-04-26"}
{"symbol": "LLY", "publishedDate": "2024-04-27 07:15:00", "publisher": "The Motley Fool", "title": "3 Dividend Stocks to Buy and Hold for the Next Decade", "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-to-buy-and-hold-for-the-20240427.jpg", "site": "fool.com", "text": "AbbVie is an unstoppable passive income machine. Eli Lilly offers a sizzling stock performance and a growing dividend.", "url": "https://www.fool.com/investing/2024/04/27/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-27T07:15:00-04:00", "date_et": "2024-04-27"}
{"symbol": "LLY", "publishedDate": "2024-04-27 11:10:00", "publisher": "The Motley Fool", "title": "Forget Nvidia, These Unstoppable Stocks Are Better Buys", "image": "https://images.financialmodelingprep.com/news/forget-nvidia-these-unstoppable-stocks-are-better-buys-20240427.jpg", "site": "fool.com", "text": "Healthcare stocks can offer investors more predictable growth opportunities than artificial intelligence, where there's much more uncertainty in the long run. Eli Lilly and Novo Nordisk have top drugs that can help diabetes and obesity, two significant health concerns around the world.", "url": "https://www.fool.com/investing/2024/04/27/forget-nvidia-these-unstoppable-stocks-are-better/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-27T11:10:00-04:00", "date_et": "2024-04-27"}
{"symbol": "LLY", "publishedDate": "2024-04-28 13:17:00", "publisher": "The Motley Fool", "title": "Eli Lilly Just Announced More Good News: Time to Buy?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-just-announced-more-good-news-time-to-20240428.jpg", "site": "fool.com", "text": "Eli Lilly's tirzepatide aced a pair of clinical trials. The medicine's sales potential looks mouthwatering.", "url": "https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-28T13:17:00-04:00", "date_et": "2024-04-28"}
{"symbol": "LLY", "publishedDate": "2024-04-29 19:11:05", "publisher": "Zacks Investment Research", "title": "Markets Up on Tesla, Q1 Earnings; Q1 Beats After the Bell", "image": "https://images.financialmodelingprep.com/news/markets-up-on-tesla-q1-earnings-q1-beats-after-20240429.jpg", "site": "zacks.com", "text": "It's now the third straight day higher going back to Thursday of last week, and recovered from a quick drop into the red.", "url": "https://www.zacks.com/stock/news/2264549/markets-up-on-tesla-q1-earnings-q1-beats-after-the-bell?cid=CS-STOCKNEWSAPI-FT-ahead_of_wall_street-2264549", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-29T19:11:05-04:00", "date_et": "2024-04-29"}
{"symbol": "LLY", "publishedDate": "2024-04-30 06:58:09", "publisher": "CNBC", "title": "Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro", "image": "https://images.financialmodelingprep.com/news/eli-lilly-beats-on-quarterly-profit-hikes-fullyear-guidance-20240430.jpeg", "site": "cnbc.com", "text": "Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in the U.S.", "url": "https://www.cnbc.com/2024/04/30/eli-lilly-lly-earnings-q1-2024.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T06:58:09-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 07:01:00", "publisher": "Market Watch", "title": "Eli Lilly's stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro, Zepbound", "image": "https://images.financialmodelingprep.com/news/eli-lillys-stock-jumps-as-firstquarter-profit-tops-estimates-20240430.jpg", "site": "marketwatch.com", "text": "Eli Lilly & Co. shares gained more than 5% premarket on Tuesday after the company reported first-quarter profit that topped analyst expectations amid strong sales of diabetes drug Mounjaro and weight-loss treatment Zepbound. The drugmaker reported net income of $2.243 billion, or $2.48 per share, up from $1.345 billion, or $1.49 per share, in the year-earlier period.", "url": "https://www.marketwatch.com/story/eli-lillys-stock-jumps-as-first-quarter-profit-tops-estimates-amid-strong-sales-of-mounjaro-zepbound-08da33a1", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T07:01:00-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 07:08:00", "publisher": "Barrons", "title": "Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-jumps-after-earnings-beat-weightloss-drugs-20240430.jpg", "site": "barrons.com", "text": "The pharmaceutical company reported adjusted earnings of $2.58 a share for the first quarter of 2024, up 59% from the same period a year earlier. Revenue rose 26% to $8.77 billion.", "url": "https://www.barrons.com/articles/eli-lilly-earnings-stock-price-8a8b424f", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T07:08:00-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 08:22:16", "publisher": "Proactive Investors", "title": "Mounjaro drives Eli Lilly sales skyward, shares near all-time high", "image": "https://images.financialmodelingprep.com/news/mounjaro-drives-eli-lilly-sales-skyward-shares-near-alltime-20240430.jpg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY)'s weight loss medication Mounjaro drove impressive first-quarter earnings results for the US pharmaceuticals megacap. Mounjaro generated worldwide revenue of $1.81 billion in the three-month period, representing an increase from $568.5 million in the first quarter of 2023.", "url": "https://www.proactiveinvestors.com/companies/news/1046472", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T08:22:16-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 08:55:37", "publisher": "Investopedia", "title": "Dow Jones Today: Stock Futures Slip; Eli Lilly Soars on Earnings", "image": "https://images.financialmodelingprep.com/news/dow-jones-today-stock-futures-slip-eli-lilly-soars-20240430.png", "site": "investopedia.com", "text": "U.S. stock futures ticked lower in premarket trading on Tuesday as earnings reports from consumer giants continued to roll in and the Federal Reserve began its two-day policy meeting.", "url": "https://www.investopedia.com/dow-jones-today-04302024-8640937", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T08:55:37-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 08:56:04", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Tops Q1 Earnings Estimates", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-tops-q1-earnings-estimates-20240430.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $1.62 per share a year ago.", "url": "https://www.zacks.com/stock/news/2264689/eli-lilly-lly-tops-q1-earnings-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2264689", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T08:56:04-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 10:21:32", "publisher": "Investopedia", "title": "Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-surges-as-weight-loss-drugs-continue-20240430.jpg", "site": "investopedia.com", "text": "Eli Lilly (LLY) stock jumped in early trading Tuesday after the drugmaker reported first-quarter earnings that beat analysts' expectations and raised its guidance thanks to continued high demand for the company's weight-loss drugs.", "url": "https://www.investopedia.com/eli-lilly-q1-2024-earnings-stock-jumps-8640894", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T10:21:32-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 10:35:23", "publisher": "Schaeffers Research", "title": "2 Stocks Surging After Earnings This Morning", "image": "https://images.financialmodelingprep.com/news/2-stocks-surging-after-earnings-this-morning-20240430.jpg", "site": "schaeffersresearch.com", "text": "Stocks are lower across the board  today, but don't blame Eli Lilly And Co (NYSE:LLY) and 3M Co (NYSE:MMM).", "url": "https://www.schaeffersresearch.com/content/news/2024/04/30/2-stocks-surging-after-earnings-this-morning", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T10:35:23-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 10:35:38", "publisher": "Zacks Investment Research", "title": "Lilly (LLY) Reports Q1 Earnings: What Key Metrics Have to Say", "image": "https://images.financialmodelingprep.com/news/lilly-lly-reports-q1-earnings-what-key-metrics-have-20240430.jpg", "site": "zacks.com", "text": "The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.", "url": "https://www.zacks.com/stock/news/2264907/lilly-lly-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2264907", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T10:35:38-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 11:26:00", "publisher": "The Motley Fool", "title": "Why Eli Lilly Stock Is Jumping Today", "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-stock-is-jumping-today-20240430.jpg", "site": "fool.com", "text": "Lilly missed Wall Street's revenue estimate for the first quarter. However, the drugmaker easily beat the consensus Q1 earnings estimate.", "url": "https://www.fool.com/investing/2024/04/30/why-eli-lilly-stock-is-jumping-today/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T11:26:00-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 12:08:29", "publisher": "Kiplinger", "title": "Eli Lilly Stock Surges on Demand for Weight-Loss Drugs", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-surges-on-demand-for-weightloss-drugs-20240430.jpg", "site": "kiplinger.com", "text": "Eli Lilly beat earnings expectations for the first quarter and raised its outlook for the year.", "url": "https://www.kiplinger.com/investing/stocks/eli-lilly-stock-surges-on-demand-for-weight-loss-drugs", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T12:08:29-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 12:46:10", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-q1-earnings-top-sales-miss-2024-20240430.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.", "url": "https://www.zacks.com/stock/news/2265271/eli-lilly-lly-q1-earnings-top-sales-miss-2024-view-raised?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2265271", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T12:46:10-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 13:27:09", "publisher": "Seeking Alpha", "title": "Eli Lilly and Company (LLY) Q1 2024 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-q1-2024-earnings-call-20240430.jpg", "site": "seekingalpha.com", "text": "Eli Lilly and Company (NYSE:LLY ) Q1 2024 Earnings Conference Call April 30, 2024 10:00 AM ET Company Participants Joe Fletcher – Senior Vice President-Investor Relations Dave Ricks – Chief Executive Officer Anat Ashkenazi – Chief Financial Officer Dan Skovronsky – Chief Scientific Officer and President-Lilly Immunology Anne White – President-Lilly Neuroscience Jake Van Naarden – President-Loxo Patrik Jonsson – President-Lilly Diabetes and Obesity and Lilly USA Conference Call Participants Chris Schott – JPMorgan Mohit Bansal – Wells Fargo Umer Raffat – Evercore Seamus Fernandez – Guggenheim Tim Anderson – Wolfe Research Terence Flynn – Morgan Stanley Akash Tewari – Jefferies Trung Huynh – UBS Geoff Meacham – Bank of America Kerry Holford – Berenberg Steve Scala – TD Cowen Evan Seigerman – BMO Capital Markets David Risinger – Leerink Partners Louise Chen – Cantor Chris Shibutani – Goldman Sachs Carter Gould – Barclays Kripa Devarakonda – Truist Securities James Shin – Deutsche Bank Operator Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode.", "url": "https://seekingalpha.com/article/4687611-eli-lilly-and-company-lly-q1-2024-earnings-call-transcript", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T13:27:09-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-04-30 18:56:20", "publisher": "Zacks Investment Research", "title": "These 3 Companies Recently Lifted Guidance", "image": "https://images.financialmodelingprep.com/news/these-3-companies-recently-lifted-guidance-20240430.jpg", "site": "zacks.com", "text": "Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture.", "url": "https://www.zacks.com/stock/news/2265464/these-3-companies-recently-lifted-guidance?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2265464", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-04-30T18:56:20-04:00", "date_et": "2024-04-30"}
{"symbol": "LLY", "publishedDate": "2024-05-01 10:00:00", "publisher": "The Motley Fool", "title": "Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks", "image": "https://images.financialmodelingprep.com/news/nearly-50-of-billionaire-stanley-druckenmillers-portfolio-is-invested-20240501.jpg", "site": "fool.com", "text": "Stanley Druckenmiller has one of the best investing records out there. He worked closely with George Soros, helping to \"break the Bank of England.", "url": "https://www.fool.com/investing/2024/05/01/50-of-billionaire-stanley-druckenmillers-portfolio/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-01T10:00:00-04:00", "date_et": "2024-05-01"}
{"symbol": "LLY", "publishedDate": "2024-05-01 11:59:48", "publisher": "InvestorPlace", "title": "Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge", "image": "https://images.financialmodelingprep.com/news/stock-market-crash-alert-3-mustbuy-biotech-stocks-when-prices-20240501.png", "site": "investorplace.com", "text": "While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of recessions that Western economies experienced over the last 40 years or so.", "url": "https://investorplace.com/2024/05/stock-market-crash-alert-3-must-buy-biotech-stocks-when-prices-plunge/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-01T11:59:48-04:00", "date_et": "2024-05-01"}
{"symbol": "LLY", "publishedDate": "2024-05-01 12:01:09", "publisher": "Zacks Investment Research", "title": "ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook", "image": "https://images.financialmodelingprep.com/news/etfs-to-buy-as-eli-lilly-beats-q1-earnings-lifts-20240501.jpg", "site": "zacks.com", "text": "Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.", "url": "https://www.zacks.com/stock/news/2266174/etfs-to-buy-as-eli-lilly-beats-q1-earnings-lifts-outlook?cid=CS-STOCKNEWSAPI-FT-etf_news_and_commentary-2266174", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-01T12:01:09-04:00", "date_et": "2024-05-01"}
{"symbol": "LLY", "publishedDate": "2024-05-01 15:36:03", "publisher": "InvestorPlace", "title": "Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)", "image": "https://images.financialmodelingprep.com/news/q1-earnings-seasons-picks-pans-the-4-biggest-stock-20240501.png", "site": "investorplace.com", "text": "We're a little more than halfway through first-quarter earnings season, so now is the time to review this earnings season winners and losers. In general, market results have been encouraging so far.", "url": "https://investorplace.com/2024/05/q1-earnings-seasons-picks-pans-the-4-biggest-stock-winners-and-3-losers/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-01T15:36:03-04:00", "date_et": "2024-05-01"}
{"symbol": "LLY", "publishedDate": "2024-05-02 05:36:06", "publisher": "Finbold", "title": "3 stocks poised for trillion-dollar valuations to consider today", "image": "https://images.financialmodelingprep.com/news/3-stocks-poised-for-trilliondollar-valuations-to-consider-today-20240502.jpg", "site": "finbold.com", "text": "Identifying the next trillion-dollar market is a serious challenge. Reaching a trillion-dollar market cap symbolizes more than just financial success; it reflects a company's profound global impact, expansive customer base, and enduring brand influence.", "url": "https://finbold.com/3-stocks-poised-for-trillion-dollar-valuations-to-consider-today/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T05:36:06-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-02 05:36:10", "publisher": "Finbold", "title": "Is this semiconductor stock the next trillion-dollar company? Why it's worth adding to your portfolio now", "image": "https://images.financialmodelingprep.com/news/is-this-semiconductor-stock-the-next-trilliondollar-company-why-20240502.jpg", "site": "finbold.com", "text": "Many have come to believe that artificial intelligence is the next stepping stone to propel the global economy to new heights. However, the giant on whose shoulder stands the development of AI is the semiconductor sector, with its critical supply chains and exponentially growing production capacities.", "url": "https://finbold.com/is-this-semiconductor-stock-the-next-trillion-dollar-company-why-its-worth-adding-to-your-portfolio-now/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T05:36:10-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-02 05:45:00", "publisher": "The Motley Fool", "title": "Here's Why Eli Lilly Stock Remains a Screaming Buy", "image": "https://images.financialmodelingprep.com/news/heres-why-eli-lilly-stock-remains-a-screaming-buy-20240502.jpg", "site": "fool.com", "text": "Lilly's Mounjaro and Zepbound should have tremendous growth ahead. The company could have even better weight loss drugs in its pipeline.", "url": "https://www.fool.com/investing/2024/05/02/heres-why-eli-lilly-stock-remains-a-screaming-buy/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T05:45:00-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-02 10:00:00", "publisher": "InvestorPlace", "title": "3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now", "image": "https://images.financialmodelingprep.com/news/3-stocks-gunning-for-trilliondollar-status-the-players-to-20240502.png", "site": "investorplace.com", "text": "Companies have clearly defined goals: to grow their customer base, brand power, and global influence, compete with giants like Nvidia (NASDAQ: NVDA ), Meta (NASDAQ: META ), Apple (NASDAQ: AAPL ), Microsoft (NASDAQ: MSFT ) and Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ), and join the shortlist of trillion-dollar stocks.  While this sounds great, reaching a trillion-dollar market cap is a tough mountain to climb.", "url": "https://investorplace.com/2024/05/3-stocks-gunning-for-trillion-dollar-status-the-players-to-own-now/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T10:00:00-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-02 16:01:04", "publisher": "Zacks Investment Research", "title": "Earnings Season: 3 Companies Boosting Guidance", "image": "https://images.financialmodelingprep.com/news/earnings-season-3-companies-boosting-guidance-20240502.jpg", "site": "zacks.com", "text": "Earnings season continues to chug along, with results from many companies already delivered. And concerning positivity, all three of these companies' report fit the criteria, lifting outlooks following the results.", "url": "https://www.zacks.com/stock/news/2267373/earnings-season-3-companies-boosting-guidance?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2267373", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T16:01:04-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-02 19:23:00", "publisher": "The Motley Fool", "title": "1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?", "image": "https://images.financialmodelingprep.com/news/1-wall-street-analyst-thinks-eli-lilly-stock-is-20240502.jpg", "site": "fool.com", "text": "The pharmaceutical sector mainstay has attracted much attention with a recently approved drug. It also posted impressive quarterly results at the end of April.", "url": "https://www.fool.com/investing/2024/05/02/1-wall-street-analyst-thinks-eli-lilly-stock-is-go/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-02T19:23:00-04:00", "date_et": "2024-05-02"}
{"symbol": "LLY", "publishedDate": "2024-05-03 10:44:36", "publisher": "CNBC", "title": "Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide", "image": "https://images.financialmodelingprep.com/news/amgen-stock-soars-on-weight-loss-injection-progress-as-20240503.jpeg", "site": "cnbc.com", "text": "Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.", "url": "https://www.cnbc.com/2024/05/03/amgen-soars-on-weight-loss-drug-progress-novo-nordisk-eli-lilly-slide.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-03T10:44:36-04:00", "date_et": "2024-05-03"}
{"symbol": "LLY", "publishedDate": "2024-05-04 05:26:00", "publisher": "The Motley Fool", "title": "Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-raised-its-outlook-is-the-stock-a-20240504.jpg", "site": "fool.com", "text": "Eli Lilly stock is way up over the past year, but analysts who follow the company think it still has more upside. Sales of Eli Lilly's weight-management treatment are soaring and could climb much higher.", "url": "https://www.fool.com/investing/2024/05/04/eli-lilly-raised-its-outlook-is-the-stock-a-buy-no/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-04T05:26:00-04:00", "date_et": "2024-05-04"}
{"symbol": "LLY", "publishedDate": "2024-05-04 06:45:00", "publisher": "The Motley Fool", "title": "Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?", "image": "https://images.financialmodelingprep.com/news/can-pfizer-challenge-lilly-and-novo-nordisk-in-the-20240504.jpg", "site": "fool.com", "text": "The outlook for Pfizer's experimental obesity drug danuglipron is murky at best. Pfizer could pick up another obesity drug via an acquisition, but management says a near-term deal is unlikely.", "url": "https://www.fool.com/investing/2024/05/04/can-pfizer-challenge-lilly-and-novo-nordisk-in-the/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-04T06:45:00-04:00", "date_et": "2024-05-04"}
{"symbol": "LLY", "publishedDate": "2024-05-04 12:00:00", "publisher": "InvestorPlace", "title": "Don't Wait for Fed to Cut Rates. Profit Now!", "image": "https://images.financialmodelingprep.com/news/dont-wait-for-fed-to-cut-rates-profit-now-20240504.png", "site": "investorplace.com", "text": "Investors wait for the Fed starting gun", "url": "https://investorplace.com/2024/05/dont-wait-for-fed-to-cut-rates-profit-now/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-04T12:00:00-04:00", "date_et": "2024-05-04"}
{"symbol": "LLY", "publishedDate": "2024-05-05 06:55:00", "publisher": "The Motley Fool", "title": "3 No-Brainer Stocks to Buy in May", "image": "https://images.financialmodelingprep.com/news/3-nobrainer-stocks-to-buy-in-may-20240505.jpg", "site": "fool.com", "text": "It's always a good time to buy shares of Eli Lilly. Pfizer is undervalued and underrated.", "url": "https://www.fool.com/investing/2024/05/05/3-no-brainer-stocks-to-buy-in-may/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-05T06:55:00-04:00", "date_et": "2024-05-05"}
{"symbol": "LLY", "publishedDate": "2024-05-05 14:49:00", "publisher": "The Motley Fool", "title": "3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years", "image": "https://images.financialmodelingprep.com/news/3-supersafe-dividend-stocks-that-have-been-making-recurring-20240505.jpg", "site": "fool.com", "text": "Eli Lilly not only has an impressive track record for paying dividends but has also doubled its payouts in just five years. Coca-Cola has a dividend growth streak that spans 62 years.", "url": "https://www.fool.com/investing/2024/05/05/3-super-safe-dividend-stocks-that-have-been-making/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-05T14:49:00-04:00", "date_et": "2024-05-05"}
{"symbol": "LLY", "publishedDate": "2024-05-06 04:10:00", "publisher": "The Motley Fool", "title": "2 Top Stocks That Could Make You Richer in 2024", "image": "https://images.financialmodelingprep.com/news/2-top-stocks-that-could-make-you-richer-in-20240506.jpg", "site": "fool.com", "text": "Alphabet just announced its first-ever dividend and a whopping $70 billion stock buyback. Eli Lilly's blockbuster weight-loss treatment is changing its customers' lives -- and delivering fortune-building gains to its shareholders.", "url": "https://www.fool.com/investing/2024/05/06/2-top-stocks-that-will-make-you-richer-in-2024/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-06T04:10:00-04:00", "date_et": "2024-05-06"}
{"symbol": "LLY", "publishedDate": "2024-05-06 10:01:11", "publisher": "Zacks Investment Research", "title": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-a-trending-stock-20240506.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2268511/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2268511", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-06T10:01:11-04:00", "date_et": "2024-05-06"}
{"symbol": "LLY", "publishedDate": "2024-05-06 10:21:04", "publisher": "Zacks Investment Research", "title": "Lilly (LLY) Reliance on International Sales: What Investors Need to Know", "image": "https://images.financialmodelingprep.com/news/lilly-lly-reliance-on-international-sales-what-investors-need-20240506.jpg", "site": "zacks.com", "text": "Examine the evolution of Lilly's (LLY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.", "url": "https://www.zacks.com/stock/news/2268816/lilly-lly-reliance-on-international-sales-what-investors-need-to-know?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_international_revenues-2268816", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-06T10:21:04-04:00", "date_et": "2024-05-06"}
{"symbol": "LLY", "publishedDate": "2024-05-06 11:32:00", "publisher": "PRNewsWire", "title": "Lilly Declares Second-Quarter 2024 Dividend", "image": "https://images.financialmodelingprep.com/news/lilly-declares-secondquarter-2024-dividend-20240506.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , May 6, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. The dividend is payable on June 10, 2024, to shareholders of record at the close of business on May 16, 2024.", "url": "https://www.prnewswire.com/news-releases/lilly-declares-second-quarter-2024-dividend-302136873.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-06T11:32:00-04:00", "date_et": "2024-05-06"}
{"symbol": "LLY", "publishedDate": "2024-05-06 19:06:54", "publisher": "The Motley Fool", "title": "Why Eli Lilly Stock Jumped by 4% Today", "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-stock-jumped-by-4-today-20240506.jpg", "site": "fool.com", "text": "The pharmaceutical powerhouse continues to remunerate its shareholders. It declared a fresh quarterly dividend.", "url": "https://www.fool.com/investing/2024/05/06/why-eli-lilly-stock-jumped-by-4-today/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-06T19:06:54-04:00", "date_et": "2024-05-06"}
{"symbol": "LLY", "publishedDate": "2024-05-07 10:12:23", "publisher": "Reuters", "title": "US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10", "image": "https://images.financialmodelingprep.com/news/us-fda-panel-to-discuss-eli-lilly-alzheimers-drug-20240507.jpg", "site": "reuters.com", "text": "Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approve its Alzheimer's disease drug, donanemab, on June 10.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-discuss-eli-lilly-alzheimers-drug-june-10-2024-05-07/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-07T10:12:23-04:00", "date_et": "2024-05-07"}
{"symbol": "LLY", "publishedDate": "2024-05-07 11:33:29", "publisher": "CNBC", "title": "Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance", "image": "https://images.financialmodelingprep.com/news/amgen-newer-rivals-could-threaten-novo-nordisk-and-eli-20240507.jpeg", "site": "cnbc.com", "text": "Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.", "url": "https://www.cnbc.com/2024/05/07/amgen-could-threaten-novo-nordisk-eli-lilly-weight-loss-drug-dominance.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-07T11:33:29-04:00", "date_et": "2024-05-07"}
{"symbol": "LLY", "publishedDate": "2024-05-07 14:04:24", "publisher": "InvestorPlace", "title": "Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare", "image": "https://images.financialmodelingprep.com/news/biotech-breakthroughs-7-stocks-driving-the-next-wave-in-20240507.png", "site": "investorplace.com", "text": "Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs.", "url": "https://investorplace.com/2024/05/biotech-breakthroughs-7-stocks-driving-the-next-wave-in-healthcare/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-07T14:04:24-04:00", "date_et": "2024-05-07"}
{"symbol": "LLY", "publishedDate": "2024-05-07 15:15:25", "publisher": "CNBC", "title": "Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply", "image": "https://images.financialmodelingprep.com/news/healthy-returns-eli-lilly-novo-nordisk-make-progress-toward-20240507.jpeg", "site": "cnbc.com", "text": "Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.", "url": "https://www.cnbc.com/2024/05/07/healthy-returns-eli-lilly-novo-nordisk-boost-weight-loss-drug-supply.html", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-07T15:15:25-04:00", "date_et": "2024-05-07"}
{"symbol": "LLY", "publishedDate": "2024-05-09 10:34:23", "publisher": "InvestorPlace", "title": "7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025", "image": "https://images.financialmodelingprep.com/news/7-weight-loss-drug-stocks-poised-for-explosive-growth-20240509.png", "site": "investorplace.com", "text": "Investors are well aware of the explosive growth potential in weight loss drug stocks. That growth began last year with Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ).", "url": "https://investorplace.com/2024/05/7-weight-loss-drug-stocks-poised-for-explosive-growth-by-2025/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-09T10:34:23-04:00", "date_et": "2024-05-09"}
{"symbol": "LLY", "publishedDate": "2024-05-09 13:10:42", "publisher": "Investors Business Daily", "title": "Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?", "image": "https://images.financialmodelingprep.com/news/is-eli-lilly-stock-a-buy-or-a-sell-20240405.jpg", "site": "investors.com", "text": "The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?", "url": "https://www.investors.com/news/technology/eli-lilly-stock-buy-now/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-09T13:10:42-04:00", "date_et": "2024-05-09"}
{"symbol": "LLY", "publishedDate": "2024-05-09 16:21:06", "publisher": "Zacks Investment Research", "title": "3 Stocks to Buy Following Guidance Upgrades", "image": "https://images.financialmodelingprep.com/news/3-stocks-to-buy-following-guidance-upgrades-20240509.jpg", "site": "zacks.com", "text": "Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture. And that's precisely what these three companies have recently announced.", "url": "https://www.zacks.com/commentary/2271746/3-stocks-to-buy-following-guidance-upgrades?cid=CS-STOCKNEWSAPI-FT-investment_ideas-2271746", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-09T16:21:06-04:00", "date_et": "2024-05-09"}
{"symbol": "LLY", "publishedDate": "2024-05-10 08:30:51", "publisher": "Investors Business Daily", "title": "Five S&P 500 Stocks To Watch In Today's Market; Amazon Stock Hits New High", "image": "https://images.financialmodelingprep.com/news/five-sp-500-stocks-to-watch-in-todays-market-20240510.jpg", "site": "investors.com", "text": "These S&P 500 stocks are industry leaders with good fundamentals and bullish charts. They may be ones you want to look at as you add exposure.", "url": "https://www.investors.com/research/sp-500-stocks-to-buy-and-watch-in-todays-market/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-10T08:30:51-04:00", "date_et": "2024-05-10"}
{"symbol": "LLY", "publishedDate": "2024-05-10 12:41:55", "publisher": "InvestorPlace", "title": "Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season", "image": "https://images.financialmodelingprep.com/news/earningsproof-tech-plays-3-stocks-set-to-stay-hot-20240510.png", "site": "investorplace.com", "text": "Depending on where you look, there has been quite a tough crowd of investors to please this earnings season. Indeed, some companies still managed to blow away the numbers.", "url": "https://investorplace.com/2024/05/earnings-proof-tech-plays-3-stocks-set-to-stay-hot-beyond-reporting-season/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-10T12:41:55-04:00", "date_et": "2024-05-10"}
{"symbol": "LLY", "publishedDate": "2024-05-11 08:45:00", "publisher": "The Motley Fool", "title": "1 No-Brainer Growth Stock to Buy and Hold", "image": "https://images.financialmodelingprep.com/news/1-nobrainer-growth-stock-to-buy-and-hold-20240511.jpg", "site": "fool.com", "text": "Eli Lilly hit it out of the park once again with its latest financial results. The company has several regulatory catalysts on the horizon.", "url": "https://www.fool.com/investing/2024/05/11/1-no-brainer-growth-stock-to-buy-and-hold/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-11T08:45:00-04:00", "date_et": "2024-05-11"}
{"symbol": "LLY", "publishedDate": "2024-05-13 07:00:00", "publisher": "InvestorPlace", "title": "The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory", "image": "https://images.financialmodelingprep.com/news/the-mustwatch-list-3-stocks-to-snap-up-as-20240513.jpg", "site": "investorplace.com", "text": "High interest rates are here to stay. Federal Reserve Chairman Jerome Powell said the fight against inflation had stalled and the central bank was leaving interest rates unchanged.", "url": "https://investorplace.com/2024/05/the-must-watch-list-3-stocks-to-snap-up-as-soon-as-they-hit-bargain-territory/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-13T07:00:00-04:00", "date_et": "2024-05-13"}
{"symbol": "LLY", "publishedDate": "2024-05-13 08:30:29", "publisher": "Forbes", "title": "Is Eli Lilly Stock A Better Pick Over Amgen?", "image": "https://images.financialmodelingprep.com/news/is-eli-lilly-stock-a-better-pick-over-amgen-20240513.jpg", "site": "forbes.com", "text": "Given its better prospects, we believe Eli Lilly stock (NYSE: LLY) is a better pick than Amgen stock (NASDAQ NASDAQ : AMGN). Both stocks have been in the limelight lately, given their focus on the lucrative weight-loss treatment market.", "url": "https://www.forbes.com/sites/greatspeculations/2024/05/13/is-eli-lilly-stock-a-better-pick-over-amgen/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-13T08:30:29-04:00", "date_et": "2024-05-13"}
{"symbol": "LLY", "publishedDate": "2024-05-14 06:30:00", "publisher": "InvestorPlace", "title": "Biotech Behemoths: 3 Giants Set to Dominate the Health Scene", "image": "https://images.financialmodelingprep.com/news/biotech-behemoths-3-giants-set-to-dominate-the-health-20240514.jpg", "site": "investorplace.com", "text": "Biotechnology is an interesting place to look if you're looking for growth and are not put off by severe levels of volatility. Undoubtedly, there's a bit of speculative zest regarding some of the smaller biotech stocks out there, many of whom depend on just a handful of pipeline candidates.", "url": "https://investorplace.com/2024/05/biotech-behemoths-3-giants-set-to-dominate-the-health-scene/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-14T06:30:00-04:00", "date_et": "2024-05-14"}
{"symbol": "LLY", "publishedDate": "2024-05-14 06:30:00", "publisher": "The Motley Fool", "title": "3 Magnificent Stocks That Are Passive Income Machines", "image": "https://images.financialmodelingprep.com/news/3-magnificent-stocks-that-are-passive-income-machines-20240514.jpg", "site": "fool.com", "text": "Eli Lilly is an ideal stock for growth and dividends. AbbVie is a Dividend King with a bright future.", "url": "https://www.fool.com/investing/2024/05/14/3-magnificent-stocks-that-are-passive-income-machi/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-14T06:30:00-04:00", "date_et": "2024-05-14"}
{"symbol": "LLY", "publishedDate": "2024-05-14 09:53:00", "publisher": "The Motley Fool", "title": "2 Top Pharma Stocks That Just Keep Getting Better and Better", "image": "https://images.financialmodelingprep.com/news/2-top-pharma-stocks-that-just-keep-getting-better-20240514.jpg", "site": "fool.com", "text": "Eli Lilly and Novo Nordisk are competing in treating diabetes and obesity. Both have launched successful products in these two markets.", "url": "https://www.fool.com/investing/2024/05/14/2-top-pharma-stocks-that-just-keep-getting-better/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-14T09:53:00-04:00", "date_et": "2024-05-14"}
{"symbol": "LLY", "publishedDate": "2024-05-14 17:58:40", "publisher": "Reuters", "title": "Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reaches-settlement-with-spa-selling-mounjaro-zepbound-20240514.jpg", "site": "reuters.com", "text": "Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular diabetes drug Mounjaro and weight loss treatment Zepbound, the drugmaker said on Tuesday.", "url": "https://www.reuters.com/legal/eli-lilly-reaches-settlement-with-spa-selling-mounjaro-zepbound-knockoffs-2024-05-14/", "ticker": "LLY", "event_date": "2024-04-30", "window_start": "2024-04-16", "window_end": "2024-05-14", "publishedDateET": "2024-05-14T17:58:40-04:00", "date_et": "2024-05-14"}
